Biomarker Market Research Reports

KEY FINDINGS The Asia Pacific non-alcoholic steatohepatitis (NASH) biomarker market is predicted to record a CAGR of 23.00% during the forecast period, 2021-2028. The rising health awareness is among the primary drivers of market growth, along...

KEY FINDINGS The North America non-alcoholic steatohepatitis (NASH) biomarker market is projected to register a CAGR of 20.02%, over the forecast period of 2021 to 2028. The favorable reimbursements across the healthcare infrastructure, the an...

KEY FINDINGS The Europe non-alcoholic steatohepatitis (NASH) biomarker market is predicted to grow at a CAGR of 19.55% during the forecast period, 2021-2028. The growing awareness about NAFLD, the increasing R&D activities for developing NASH ...

KEY FINDINGS The United States non-alcoholic steatohepatitis (NASH) biomarker market is registered to grow with a CAGR of 20.70%, during the forecast years. The increased incidence of non-alcoholic fatty liver (NAFL) disease, as well as the ri...

KEY FINDINGS The North American cancer biomarker market is all set to expand with a CAGR of 10.41% between the forecasted years of 2019-2027. The region holds the highest share in the global cancer biomarker market and also contribute the maxi...

KEY FINDINGS The Europe cancer biomarker market is poised to grow at a CAGR of 10.83% for the years 2019-2027. Technological progress in research and developmental activities has progressed the growth of the cancer biomarker market in Europe....

KEY FINDINGS The Asia-Pacific cancer biomarkers market is expected to rise with a CAGR of 13.23% for the years 2019-2027. Development in the healthcare facility in the region and growing government efforts to increase awareness are the major d...

Key Findings The United States is a primary contributor to the North American cancer biomarker market, which is all set to expand with a CAGR of 13.17% between the forecasted years of 2017-2025. The market collections are also predicted to inc...

Key Findings The Europe cancer biomarker market is poised to grow at a CAGR of 13.46% for the years 2017-2025. The total income generated by the market is also predicted to increase to up to $8646 million by the end of this forecast period....

Key Findings The Asia-Pacific cancer biomarkers market is expected to speed up its growth with a CAGR of 15.73% for the years 2017-2025, generating a net worth of $8831 million. India is the fastest growing market in the Asia-Pacific region....

This study covers the world outlook for central nervous system (CNS) biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i...

This study covers the world outlook for biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ...

This study covers the world outlook for cardiac biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. do...

This study covers the world outlook for cancer biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol...

This study covers the world outlook for diagnostic biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S....

This study covers the world outlook for biomarker systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol...

"US Biomarkers Inc. Company Profile" is a complete analysis of the company's operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future plans and projects bei...

"Toscana Biomarkers Srl Company Profile" is a complete analysis of the company's operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future plans and projects...

"Stemina Biomarker Discovery, Inc Company Profile" is a complete analysis of the company's operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future plans an...

"Banyan Biomarkers Inc. Company Profile" is a complete analysis of the company's operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future plans and projects...

"ACS Biomarker Company Profile" is a complete analysis of the company's operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile, future plans and projects being pl...